Atreca Inc
NASDAQ:BCEL
Atreca Inc
Interest Income Expense
Atreca Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Atreca Inc
NASDAQ:BCEL
|
Interest Income Expense
$820k
|
CAGR 3-Years
-36%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Interest Income Expense
-$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Interest Income Expense
-$757m
|
CAGR 3-Years
35%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Interest Income Expense
-$2.9B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-16%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Interest Income Expense
$563.1m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Interest Income Expense
$221.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is Atreca Inc's Interest Income Expense?
Interest Income Expense
820k
USD
Based on the financial report for Dec 31, 2022, Atreca Inc's Interest Income Expense amounts to 820k USD.
What is Atreca Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
42%
Over the last year, the Interest Income Expense growth was 310%. The average annual Interest Income Expense growth rates for Atreca Inc have been -36% over the past three years , 42% over the past five years .